Aggressive Behavior of Nonmelanotic Skin Cancers in Solid Organ Transplant Recipients

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Transplantation

• Publication date

  2010-09-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/TP.0b013e3181ec7228PMID 20808266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TGF-β-induced epithelial to mesenchymal transition

  2009cited by this paper
• Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin.

  2006cited by this paper
• A population‐based study of skin cancer incidence and prevalence in renal transplant recipients

  2006cited by this paper
• Special concern about squamous cell carcinoma of the scalp in organ transplant recipients.

  2006cited by this paper
• Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series.

  2006cited by this paper
• Management of skin cancer in solid organ transplant recipients

  2005cited by this paper
• Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience.

  2005cited by this paper
• Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.

  2004cited by this paper
• Histologic Features in Primary Cutaneous Squamous Cell Carcinomas in Immunocompromised Patients Focusing on Organ Transplant Patients

  2004cited by this paper
• Skin cancers after organ transplantation.

  2003cited by this paper
• A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non‐melanoma skin cancers and solar keratosis

  2003cited by this paper
• Skin cancers after organ transplantation.

  2003cited by this paper
• European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment.

  2002cited by this paper
• Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants.

  2001cited by this paper
• Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients.

  2000cited by this paper
• Human papillomavirus infection and non‐melanoma skin cancer in immunosuppressed and immunocompetent individuals

  2000cited by this paper
• Cancers in renal transplant recipients.

  2000cited by this paper
• Cyclosporine induces cancer progression by a cell-autonomous mechanism

  1999cited by this paper
• High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study.

  1998cited by this paper
• Prevailing papillomavirus types in non‐melanoma carcinomas of the skin in renal allograft recipients

  1997cited by this paper
• Nonmelanoma Skin Cancer Mortality

  1996influential reference
• Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients.

  1996cited by this paper
• PHOTOCHEMICAL SENSITIZATION BY AZATHIOPRINE AND ITS METABOLITES. PART 3. A DIRECT EPR AND SPIN‐TRAPPING STUDY OF LIGHT‐INDUCED FREE RADICALS FROM 6‐MERCAPTOPURINE AND ITS OXIDATION PRODUCTS

  1994cited by this paper
• De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.

  1993cited by this paper
• Human papilloma virus infection and skin cancer in renal allograft recipients.

  1989cited by this paper
• ABILITY OF CYCLOSPORINE TO PROMOTE THE GROWTH OF TRANSPLANTED ULTRAVIOLET RADIATION‐INDUCED TUMORS IN MICE

  1987cited by this paper
• Skin cancer in renal transplant recipients is associated with increased concentrations of 6‐thioguanine nucleotide in red blood cells

  1985cited by this paper
• Cancer, warts, and sunshine in renal transplant patients. A case-control study.

  1984cited by this paper
• Malignant lymphomas in transplantation patients.

  1969cited by this paper
• Renal transplantation.

  1967influential reference

• Skin lesion triage in organ transplant recipients using line-field confocal optical coherence tomography: a retrospective classification study.

  2026cites this paper
• Management of Cutaneous Squamous Cell Carcinoma of the Scalp in Kidney Transplant Recipients

  2025cites this paper
• Society of Surgical Oncology Medical Student & Trainee Primer for Skin, Soft Tissue, and Endocrine Surgical Oncology

  2025cites this paper
• Impact of Immunosuppression on Cutaneous Squamous Cell Carcinoma Outcomes.

  2025cites this paper
• Management of Cutaneous Squamous Cell Carcinoma: A Literature Review and Update.

  2025cites this paper
• Cutaneous Squamous Cell Carcinoma Risk Factors: Are Current Criteria Still Valid? A Retrospective, Monocenter Analysis

  2025cites this paper
• Different Course of Nonpigmented Skin Cancers in Patients Treated with Immunosuppression after Organ Transplantation: A Case Series

  2025cites this paper
• S2k‐Leitlinie Basalzellkarzinom der Haut (Aktualisierung 2023)

  2024cites this paper
• S2k guideline basal cell carcinoma of the skin (update 2023)

  2024cites this paper
• Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression

  2024cites this paper
• Immunotherapy for Advanced Skin Cancer in Kidney Transplant Recipients-The High-Risk Balancing Act.

  2024cites this paper
• Cutaneous squamous cell carcinoma in solid organ transplant recipients: Current therapeutic and screening strategies.

  2024cites this paper
• Malignancy risk and mortality after lung transplantation: A single-institution experience over 31 years

  2024cites this paper
• Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.

  2023cites this paper
• Surgery Alone (Without Adjuvant Radiation) Adequately Treats Histologic Perineural Basal Cell Carcinomas: A Systematic Review With Meta-Analysis

  2023cites this paper
• Toward a robust swallowing detection for an implantable active artificial larynx: a survey

  2023cites this paper
• Prevention and Treatment of HPV-Induced Skin Tumors

  2023cites this paper
• The Tumor Immune Microenvironment in Cutaneous Squamous Cell Carcinoma Arising in Organ Transplant Recipients.

  2023cites this paper
• The Role of Radiation Therapy in the Treatment of Non-Melanoma Skin Cancer

  2023cites this paper
• Recommendations for risk stratification of periocular squamous cell carcinoma.

  2023cites this paper
• Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

  2023cites this paper
• Perineural Invasion in Cutaneous Squamous Cell Carcinoma in a Cohort of Renal Transplant Patients Versus Immunocompetent Patients: The Irish Experience.

  2023cites this paper
• German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – long version of the update 2023

  2023cites this paper
• Management of Cutaneous Head and Neck Squamous and Basal Cell Carcinomas for Immunocompromised Patients

  2023cites this paper
• High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population.

  2023cites this paper
• Exhaustion of CD8+ central memory responder T cell differentiation provokes non-melanoma skin cancer in elderly kidney transplant recipients

  2023cites this paper
• Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids.

  2022cites this paper
• Squamous cell carcinomas in organ transplant recipients. Comparison of histopathological and clinical features of squamous cell carcinoma in patients after organ transplantation to immunocompetent patients

  2022cites this paper
• Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients

  2022cites this paper
• Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual center retrospective cohort analysis of primary N0 disease.

  2022cites this paper
• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

  2022cites this paper
• Pathways from Diagnosis to Death from Keratinocyte Cancer in Kidney Transplant Recipients

  2022cites this paper
• Predictors of Nodal Metastasis in Cutaneous Head and Neck Cancers

  2022cites this paper
• Cutaneous Head and Neck Cancers in the High-Risk Immunosuppressed Population.

  2021cites this paper
• Non-surgical treatments for basal cell skin cancer

  2021cites this paper
• Сlinical features of malignant tumors against the background of immunosuppressive therapy in heart transplant recipients

  2021influential citation
• Oral health of patients suffering from end-stage solid organ insufficiency prior to solid organ re-transplantation: a retrospective case series study

  2021cites this paper
• Особенности течения злокачественных новообразований на фоне иммуносупрессивной терапии у реципиентов сердца

  2021cites this paper
• Epidemiology of advanced cutaneous squamous cell carcinoma

  2021cites this paper
• The association between immunosuppression and skin cancer in solid organ transplant recipients: a control-matched cohort study of 2,852 patients

  2021cites this paper
• Keratinocyte Cancer Mortality in Kidney Transplant Recipients

  2021cites this paper
• Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?

  2021cites this paper
• Parotid metastases of cutaneous squamous cell carcinoma in renal transplant recipients: Case series and literature review

  2021cites this paper
• Cutaneous squamous cell carcinoma in the organ transplant recipient.

  2020cites this paper
• Cancer survival in kidney transplant recipients in Ireland.

  2020cites this paper
• Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.

  2020cites this paper
• Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region—Comparison between solid organ transplant recipients and immunocompetent patients

  2020influential citation
• Sparsity of dendritic cells and cytotoxic T cells in tumor microenvironment may lead to recurrence in basal cell carcinoma

  2020cites this paper
• Actinic keratoses: Reconciling the biology of field cancerization with treatment paradigms.

  2020cites this paper
• Diagnosis and Treatment of Basal Cell Carcinoma in Specialized Dermatology Units: A Clinical Practice Guideline.

  2020cites this paper
• Update: Solar UV Radiation, Vitamin D, and Skin Cancer Surveillance in Organ Transplant Recipients (OTRs).

  2020cites this paper
• The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients

  2020cites this paper
• Diagnosis and Treatment of Basal Cell Carcinoma in Specialized Dermatology Units: A Clinical Practice Guideline

  2020cites this paper
• Basal Cell Carcinoma: Advances in Treatment and Research

  2020cites this paper
• The Role of the Immune System in Cutaneous Squamous Cell Carcinoma

  2019cites this paper
• Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention.

  2019cites this paper
• S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow‐up

  2019cites this paper
• S2k‐Leitlinie Basalzellkarzinom der Haut – Teil 2: Therapie, Prävention und Nachsorge

  2019cites this paper
• Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy

  2019cites this paper
• Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? a systematic review and meta‐analysis

  2019cites this paper
• Case-Control Study of Tumor Stage-Dependent Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed and Immunocompetent Patients.

  2019cites this paper
• MESTRADO INTEGRADO EM MEDICINA – TRABALHO FINAL

  2019cites this paper
• Surgical Treatment for Basal Cell Carcinoma of the Head and Neck

  2019cites this paper
• Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients

  2019cites this paper
• Plattenepithelkarzinom der Haut

  2019cites this paper
• Does Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck Warrant Adjuvant Treatment After Surgical Resection?

  2019cites this paper
• Cutaneous Lesions that Mimic Infection in Transplant Patients

  2019cites this paper
• Unraveling cancer lineage drivers in squamous cell carcinomas.

  2019cites this paper
• Basalzellkarzinom der Gesichts- und Kopfhaut

  2018cites this paper
• Guidelines of care for the management of cutaneous squamous cell carcinoma.

  2018cites this paper
• Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients

  2018cites this paper
• Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy

  2018cites this paper
• Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients

  2018cites this paper
• Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion

  2018cites this paper
• Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?

  2018cites this paper
• Guidelines of care for the management of basal cell carcinoma.

  2018cites this paper
• Specific knockdown of HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and invasion while inducing apoptosis via the Wnt/β-catenin signaling pathway.

  2018cites this paper
• Nonmelanoma skin cancer of the head and neck region in solid organ transplant recipients

  2018cites this paper
• Guidelines of care for the management of cutaneous squamous cell carcinoma

  2018cites this paper
• High-Risk Cutaneous Squamous Cell Carcinoma

  2018cites this paper
• Squamous Cell Carcinoma

  2018cites this paper
• Basalzellkarzinom der Gesichts- und Kopfhaut

  2018cites this paper
• Management of the Neck for Non-melanoma Skin Cancer

  2018cites this paper
• Title Guidelines of care for the management of basal cell carcinoma Permalink

  2018cites this paper
• Cutaneous Squamous Cell Carcinomas In Solid Organ Transplant Recipients: A Single-Center Experience

  2017influential citation
• A review of the role of external-beam radiation therapy in nonmelanomatous skin cancer

  2017cites this paper
• A multi‐institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck

  2017cites this paper
• Papel de los fármacos inhibidores de mTOR en la prevención del cáncer cutáneo no melanoma en los pacientes receptores de un trasplante de órgano sólido

  2017cites this paper
• Skin Cancer In Solid Organtransplant Recipients

  2017cites this paper
• Practical indications for the management of non-melanoma skin cancer patients.

  2017cites this paper
• Evaluating Retention of Skin Cancer Education in Kidney Transplant Recipients Reveals a Window of Opportunity for Re-education.

  2017cites this paper
• Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation

  2017cites this paper
• Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients

  2017cites this paper
• Malignancies After Heart Transplant.

  2016cites this paper
• NCCN Basal Cell Skin Cancer , Version 1 . 2016 Clinical Practice Guidelines in Oncology

  2016cites this paper
• Forward to the Past-Oncology Between Underdiagnosis and Overtreatment.

  2016cites this paper
• Management of squamous cell and basal cell carcinomas of the head and neck with perineural invasion

  2016cites this paper
• Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment.

  2016cites this paper
• Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Collaborative (ITSCC)

  2016cites this paper
• Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation – experiences from a prospective, clinical, observational study

  2016cites this paper